APA

Hackeng W. M., Morsink F. H. M., Moons L. M. G., Heaphy C. M., Offerhaus G. J. A., Dreijerink K. M. A. & Brosens L. A. A. (20201119). Assessment of ARX expression, a novel biomarker for metastatic risk in pancreatic neuroendocrine tumors, in endoscopic ultrasound fine-needle aspiration. : Diagnostic cytopathology.

Chicago

Hackeng Wenzel M, Morsink Folkert H M, Moons Leon M G, Heaphy Christopher M, Offerhaus G Johan A, Dreijerink Koen M A and Brosens Lodewijk A A. 20201119. Assessment of ARX expression, a novel biomarker for metastatic risk in pancreatic neuroendocrine tumors, in endoscopic ultrasound fine-needle aspiration. : Diagnostic cytopathology.

Harvard

Hackeng W. M., Morsink F. H. M., Moons L. M. G., Heaphy C. M., Offerhaus G. J. A., Dreijerink K. M. A. and Brosens L. A. A. (20201119). Assessment of ARX expression, a novel biomarker for metastatic risk in pancreatic neuroendocrine tumors, in endoscopic ultrasound fine-needle aspiration. : Diagnostic cytopathology.

MLA

Hackeng Wenzel M, Morsink Folkert H M, Moons Leon M G, Heaphy Christopher M, Offerhaus G Johan A, Dreijerink Koen M A and Brosens Lodewijk A A. Assessment of ARX expression, a novel biomarker for metastatic risk in pancreatic neuroendocrine tumors, in endoscopic ultrasound fine-needle aspiration. : Diagnostic cytopathology. 20201119.